What The Delay Of A Promising Muscular Dystrophy Drug Means For...

In the late 1990s Regeneron, the biotechnology company based in Tarrytown, NY, was developing a treatment for amyotrophic lateral sclerosis , better known as Lou Gehrig's disease, which cause paralysis and then death.

http://www.biospace.com/news_story.aspx?StoryID=315531&full=1